US Patent 9321765 Crystalline bromodomain inhibitors
Patent 9321765 was granted and assigned to AbbVie Inc. on April, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+285 characters)
Article
Patent abstract
N-[4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]ethanesulfonamide and crystalline forms thereof are suitable pharmaceutical ingredients for pharmaceutical compositions useful in the treatment of disease, for example, cancer.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Yuchuan Gong0
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09321765 Crystalline bromodomain inhibitors US Patent 9321765 Crystalline bromodomain inhibitors
Infobox
Patent Number
09321765
Patent Number
9321765
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09321765 Crystalline bromodomain inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09321765
Date of patent
April 26, 2016
Patent application number
14317029
Date Filed
June 27, 2014
Patent primary examiner
Find more entities like US Patent 9321765 Crystalline bromodomain inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
